Expanded access programmes: Patient interests versus clinical trial integrity

Paul Lorigan, Paolo A. Ascierto, Reinhard Dummer, Alexander M. Eggermont, Keith T. Flaherty, Claus Garbe, Helen Gogas, Axel Hauschild, Richard F. Kefford, John M. Kirkwood, James Larkin, Georgina V. Long, Michele Maio, Grant A. McArthur, Antoni Ribas, Caroline Robert, Dirk Schadendorf, Vernon K. Sondak, Jedd D. Wolchok, Andrew M. Hudson

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)15-17
Number of pages3
JournalThe Lancet Oncology
Volume16
Issue number1
DOIs
Publication statusPublished - 2015

ASJC Scopus subject areas

  • Oncology

Cite this

Lorigan, P., Ascierto, P. A., Dummer, R., Eggermont, A. M., Flaherty, K. T., Garbe, C., Gogas, H., Hauschild, A., Kefford, R. F., Kirkwood, J. M., Larkin, J., Long, G. V., Maio, M., McArthur, G. A., Ribas, A., Robert, C., Schadendorf, D., Sondak, V. K., Wolchok, J. D., & Hudson, A. M. (2015). Expanded access programmes: Patient interests versus clinical trial integrity. The Lancet Oncology, 16(1), 15-17. https://doi.org/10.1016/S1470-2045(14)71161-1